SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 27.93 |
| Enterprise Value ($M) | 28.70 |
| Book Value ($M) | 74.10 |
| Book Value / Share | 8.62 |
| Price / Book | 0.38 |
| NCAV ($M) | -28.33 |
| NCAV / Share | -3.30 |
| Price / NCAV | -0.99 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.53 |
| Return on Assets (ROA) | -0.40 |
| Return on Equity (ROE) | -0.46 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.17 |
| Current Ratio | 0.40 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 14.22 |
| Assets | 116.65 |
| Liabilities | 42.55 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -42.00 |
| Net Income | -39.14 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -28.20 |
| Cash from Investing | -5.00 |
| Cash from Financing | 9.97 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Mazur Leonard L | 9.30 | -95.83 | |
| 13G/A | BlackRock, Inc. | 4.80 | 1.99 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 23,148 | 74,404 | 31.11 | |
| 9,426 | 58,515 | 16.11 | |
| 24,568 | 76,961 | 31.92 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CRVO – CervoMed Inc. | CSBR – Champions Oncology, Inc. |
| CSCI – COSCIENS Biopharma Inc. | CUE – Cue Biopharma, Inc. |
| CVKD – Cadrenal Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io